Clinical statistical analysis shows that the overexpression of SOX12 promotes the proliferation and metastasis of colorectal cancer (CRC) cells by activating a variety of glutamine-metabolising enzymes, including GLS1, mitochondrial aspartate aminotransferase (GOT2), and ASNS (Fig. 1) [25]. Here, GOT2 is linked to colorectal carcinoma.